Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Hutton

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseWilliam Kielbasa, Paul Goldsmith, Kevin B Donnelly, et al.
Human Molecular Genetics|August 30, 2008
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementiaRosa Rademakers, Jason L Eriksen, Matt Baker, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
American Journal of Human Genetics|December 13, 2006
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studiesJohn V Pearson, Matthew J Huentelman, Rebecca F Halperin, et al.
Neurology|August 1, 2014
Recommendations of the Alzheimer's disease-related dementias conferenceThomas J Montine, Walter J Koroshetz, Debra Babcock, et al.
Human Molecular Genetics|October 1, 2005
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsyRosa Rademakers, Stacey Melquist, Marc Cruts, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysisJennifer Webster, Eric M Reiman, Victoria L Zismann, et al.
Parkinsonism & Related Disorders|May 10, 2005
The effect of tau genotype on clinical features in FTDP-17Yasuhiko Baba, Yoshio Tsuboi, Matthew C Baker, et al.
Neurology|November 10, 2017
Alzheimer's Disease-Related Dementias Summit 2016: National research prioritiesRoderick A Corriveau, Walter J Koroshetz, Jordan T Gladman, et al.
Neurobiology of Aging|September 16, 2008
Evidence for an association between KIBRA and late-onset Alzheimer's diseaseJason J Corneveaux, Winnie S Liang, Eric M Reiman, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseWilliam Kielbasa, Paul Goldsmith, Kevin B Donnelly, et al.
Human Molecular Genetics|August 30, 2008
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementiaRosa Rademakers, Jason L Eriksen, Matt Baker, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
American Journal of Human Genetics|December 13, 2006
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studiesJohn V Pearson, Matthew J Huentelman, Rebecca F Halperin, et al.
Neurology|August 1, 2014
Recommendations of the Alzheimer's disease-related dementias conferenceThomas J Montine, Walter J Koroshetz, Debra Babcock, et al.
Human Molecular Genetics|October 1, 2005
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsyRosa Rademakers, Stacey Melquist, Marc Cruts, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysisJennifer Webster, Eric M Reiman, Victoria L Zismann, et al.
Parkinsonism & Related Disorders|May 10, 2005
The effect of tau genotype on clinical features in FTDP-17Yasuhiko Baba, Yoshio Tsuboi, Matthew C Baker, et al.
Neurology|November 10, 2017
Alzheimer's Disease-Related Dementias Summit 2016: National research prioritiesRoderick A Corriveau, Walter J Koroshetz, Jordan T Gladman, et al.
Neurobiology of Aging|September 16, 2008
Evidence for an association between KIBRA and late-onset Alzheimer's diseaseJason J Corneveaux, Winnie S Liang, Eric M Reiman, et al.
Pageof 5